Document Detail


Immunosuppressive treatment for juvenile myasthenia gravis.
MedLine Citation:
PMID:  1601015     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The result of immunosuppressive treatment in 20 cases of generalized myasthenia gravis with onset before age 16 were analysed. The patients age at the beginning of immunosuppressive treatment ranged from 10 to 22 years. Thirteen patients suffered from a severe form of myasthenia gravis with respiratory attacks, the remaining 7 demonstrated a moderately severe form with bulbar symptoms dominating the clinical picture. Indication for immunosuppressive treatment was lack of or only slight improvement after thymectomy. Prednisone was used in 17 cases, high dosage of methylprednisolone in 8 (in one case twice), azathioprine in 11 and cyclophosphamide in 10. Best results were obtained with cyclophosphamide since significant improvement was recorded in 14/20 of patients. Corticosteroids, i.e. prednisone and high-dose methylprednisolone proved to be of limited value.
Authors:
B Badurska; B Ryniewicz; H Strugalska
Related Documents :
16305295 - Asthma-related health care resource use among patients starting fluticasone or monteluk...
10515405 - Development of wheezing in patients with cough variant asthma during an increase in air...
8635375 - A comparative study of the clinical efficacy of nedocromil sodium and placebo. how does...
7596005 - Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulm...
22824435 - Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes...
1421065 - Amrinone and dobutamine as primary treatment of low cardiac output syndrome following c...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of pediatrics     Volume:  151     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  1992 Mar 
Date Detail:
Created Date:  1992-07-10     Completed Date:  1992-07-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  215-7     Citation Subset:  IM    
Affiliation:
Department of Neurology, Medical School Polish Academy of Sciences, Warsaw.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Autoimmune Diseases / drug therapy*
Azathioprine / therapeutic use
Child
Cyclophosphamide / therapeutic use
Female
Humans
Immunosuppression*
Immunosuppressive Agents / therapeutic use*
Male
Methylprednisolone / therapeutic use
Myasthenia Gravis / drug therapy*
Prednisone / therapeutic use
Chemical
Reg. No./Substance:
0/Immunosuppressive Agents; 446-86-6/Azathioprine; 50-18-0/Cyclophosphamide; 53-03-2/Prednisone; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lack of temporal relation between acid reflux in the proximal oesophagus and cardiorespiratory event...
Next Document:  Nutritional vitamin B12 deficiency: two cases detected by routine newborn urinary screening.